Your browser doesn't support javascript.
loading
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial.
Finn, Richard S; Ryoo, Baek-Yeol; Merle, Philippe; Kudo, Masatoshi; Bouattour, Mohamed; Lim, Ho Yeong; Breder, Valeriy; Edeline, Julien; Chao, Yee; Ogasawara, Sadahisa; Yau, Thomas; Garrido, Marcelo; Chan, Stephen L; Knox, Jennifer; Daniele, Bruno; Ebbinghaus, Scot W; Chen, Erluo; Siegel, Abby B; Zhu, Andrew X; Cheng, Ann-Lii.
Affiliation
  • Finn RS; University of California, Los Angeles, Los Angeles, CA.
  • Ryoo BY; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Merle P; Lyon North Hospital, Lyon, France.
  • Kudo M; Kindai University Faculty of Medicine, Osaka, Japan.
  • Bouattour M; Beaujon University Hospital, Assistance Publique-Hôpitaux de Paris, Clichy, France.
  • Lim HY; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Breder V; NN Blokhin National Medical Research Center of Oncology, Ministry of Health, Moscow, Russian Federation.
  • Edeline J; Centre Eugène Marquis, Rennes, France.
  • Chao Y; Taipei Veterans General Hospital, Taipei, Taiwan.
  • Ogasawara S; Chiba University Graduate School of Medicine, Chiba, Japan.
  • Yau T; The University at Hong Kong, Hong Kong, People's Republic of China.
  • Garrido M; Pontificia Universidad Catolica de Chile, Santiago, Chile.
  • Chan SL; State Key Laboratory of Translation Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
  • Knox J; Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.
  • Daniele B; Ospedale del Mare, Napoli, Italy.
  • Ebbinghaus SW; Merck, Kenilworth, NJ.
  • Chen E; Merck, Kenilworth, NJ.
  • Siegel AB; Merck, Kenilworth, NJ.
  • Zhu AX; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA.
  • Cheng AL; National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan.
J Clin Oncol ; 38(3): 193-202, 2020 01 20.
Article in En | MEDLINE | ID: mdl-31790344
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Liver Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2020 Document type: Article Affiliation country: Canadá
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Liver Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2020 Document type: Article Affiliation country: Canadá